Exact Mass: 257.06188000000003
Exact Mass Matches: 257.06188000000003
Found 500 metabolites which its exact mass value is equals to given mass value 257.06188000000003,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Tolmetin
Tolmetin is only found in individuals that have used or taken this drug. It is a non-steroidal anti-inflammatory agent (anti-inflammatory agents, NON-steroidal) similar in mode of action to indomethacin. [PubChem]The mode of action of tolmetin is not known. However, studies in laboratory animals and man have demonstrated that the anti-inflammatory action of tolmetin is not due to pituitary-adrenal stimulation. Tolmetin inhibits prostaglandin synthetase in vitro and lowers the plasma level of prostaglandin E in man. This reduction in prostaglandin synthesis may be responsible for the anti-inflammatory action. Tolmetin does not appear to alter the course of the underlying disease in man. M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents KEIO_ID T044; [MS2] KO009288 D004791 - Enzyme Inhibitors KEIO_ID T044
Thiobencarb
CONFIDENCE standard compound; INTERNAL_ID 645; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9919; ORIGINAL_PRECURSOR_SCAN_NO 9915 CONFIDENCE standard compound; INTERNAL_ID 645; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9872; ORIGINAL_PRECURSOR_SCAN_NO 9867 CONFIDENCE standard compound; INTERNAL_ID 645; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9934; ORIGINAL_PRECURSOR_SCAN_NO 9929 D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
meclofenoxate
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D020011 - Protective Agents
5-Methylcytidine
CONFIDENCE standard compound; INTERNAL_ID 322 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 5-Methylcytidine is a pyrimidine nucleoside detected in multiple biofluids. 5-Methylcytidine is a pyrimidine nucleoside detected in multiple biofluids.
5-Methylcytidine
5-Methylcytidine belongs to the class of organic compounds known as pyrimidine nucleosides. Pyrimidine nucleosides are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. 5-Methylcytidine is a post-transcriptional modifications found in tRNA, snRNA, and rRNA. It is associated with the genetic change which is involved in the origin of cancer (PMID 6260434). [HMDB] 5-Methylcytidine is a pyrimidine nucleoside detected in multiple biofluids. 5-Methylcytidine is a pyrimidine nucleoside detected in multiple biofluids.
Glycerophosphocholine
Glycerophosphorylcholine (GPC) is a choline derivative and one of the two major forms of choline storage (along with phosphocholine) in the cytosol. Glycerophosphorylcholine is also one of the four major organic osmolytes in renal medullary cells, changing their intracellular osmolyte concentration in parallel with extracellular tonicity during cellular osmoadaptation. As an osmolyte, Glycerophosphorylcholine counteracts the effects of urea on enzymes and other macromolecules. Kidneys (especially medullar cells), which are exposed under normal physiological conditions to widely fluctuating extracellular solute concentrations, respond to hypertonic stress by accumulating the organic osmolytes glycerophosphorylcholine (GPC), betaine, myo-inositol, sorbitol and free amino acids. Increased intracellular contents of these osmolytes are achieved by a combination of increased uptake (myo-inositol and betaine) and synthesis (sorbitol, GPC), decreased degradation (GPC) and reduced osmolyte release. GPC is formed in the breakdown of phosphatidylcholine (PtC). This pathway is active in many body tissues, including mammary tissue. Choline alfoscerate, also known as glycerophosphocholine or choline glycerophosphate, is a member of the class of compounds known as glycerophosphocholines. Glycerophosphocholines are lipids containing a glycerol moiety carrying a phosphocholine at the 3-position. Choline alfoscerate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Choline alfoscerate can be found in a number of food items such as radish, strawberry guava, yellow pond-lily, and pepper (c. baccatum), which makes choline alfoscerate a potential biomarker for the consumption of these food products. L-Alpha glycerylphosphorylcholine (alpha-GPC, choline alfoscerate) is a natural choline compound found in the brain. It is also a parasympathomimetic acetylcholine precursor which may have potential for the treatment of Alzheimers disease and other dementias . N - Nervous system > N07 - Other nervous system drugs > N07A - Parasympathomimetics C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist D013501 - Surface-Active Agents > D054709 - Lecithins COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS sn-Glycero-3-phosphocholine (Choline Alfoscerate) is a precursor in the biosynthesis of brain phospholipids and increases the bioavailability of choline in nervous tissue. sn-Glycero-3-phosphocholine (Choline Alfoscerate) has significant effects on cognitive function with a good safety profile and tolerability, and is effective in the treatment of Alzheimer's disease and dementia[1][2].
Pyro-L-glutaminyl-L-glutamine
Pyro-L-glutaminyl-L-glutamine is found in fruits. Pyro-L-glutaminyl-L-glutamine is a constituent of the seeds of Dolichos biflorus (papadi). Constituent of the seeds of Dolichos biflorus (papadi). Pyro-L-glutaminyl-L-glutamine is found in fruits.
1,3,5-Trihydroxy-10-methylacridone
1,3,5-Trihydroxy-10-methylacridone is found in citrus. 1,3,5-Trihydroxy-10-methylacridone is an alkaloid from roots of Yalaha [several hybrid seedlings resulting from a cross of Duncan grapefruit (Citrus paradisi) x Dancy tangerine (Citrus tangerina)]. Alkaloid from roots of Yalaha [several hybrid seedlings resulting from a cross of Duncan grapefruit (Citrus paradisi) x Dancy tangerine (Citrus tangerina)]. 1,3,5-Trihydroxy-10-methylacridone is found in citrus.
2-(Ethylsulfonylmethyl)phenyl methylcarbamate
Ethiofencarb metabolite. Ethiofencarb metabolite
3-Methylcytidine
3-Methylcytidine belongs to the class of organic compounds known as pyrimidine nucleosides. These are compounds comprising a pyrimidine base attached to a ribosyl or deoxyribosyl moiety. 3-Methylcytidine is a potential urinary biomarker of whole grain intake (PMID: 27805021). 3-Methylcytidine has been identified in the human placenta (PMID: 32033212). 3-Methylcytidine, a urinary nucleoside, can be used as a biomarker of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer[1].
1-[(2S,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4-imino-3-methylpyrimidin-2-one
2'-O-Methylcytidine
2'-O-Methylcytidine is a 2'-substituted nucleoside as a inhibitor of HCV replication. 2'-O-Methylcytidine inhibits RNA-dependent RNA polymerase (NS5B)-catalyzed RNA synthesis in vitro, in a manner that is competitive with substrate nucleoside triphosphate[1].
4-(N,N-Dimethylsulfamoyl)-7-hydrazino-benzofurazan
2'-C-Methylcytidine
(E)-5-(Quinoxalin-6-ylmethylene)thiazolidine-2,4-dione
C12H7N3O2S (257.02589620000003)
3-(Aminomethyl)-2,5,9-trimethyl-7H-furo[3,2-g]chromen-7-one
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D003432 - Cross-Linking Reagents D011838 - Radiation-Sensitizing Agents > D017319 - Photosensitizing Agents > D011564 - Furocoumarins D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents D003879 - Dermatologic Agents
benserazide
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor
cephalosporanic acid
C10H11NO5S (257.03579160000004)
Cystemustine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
Glycerylphosphorylcholine
Glycerophosphorylcholine (GPC) is a choline derivative and one of the two major forms of choline storage (along with phosphocholine) in the cytosol. Glycerophosphorylcholine is also one of the four major organic osmolytes in renal medullary cells, changing their intracellular osmolyte concentration in parallel with extracellular tonicity during cellular osmoadaptation. As an osmolyte, Glycerophosphorylcholine counteracts the effects of urea on enzymes and other macromolecules. Kidneys (especially medullar cells), which are exposed under normal physiological conditions to widely fluctuating extracellular solute concentrations, respond to hypertonic stress by accumulating the organic osmolytes glycerophosphorylcholine (GPC), betaine, myo-inositol, sorbitol and free amino acids. Increased intracellular contents of these osmolytes are achieved by a combination of increased uptake (myo-inositol and betaine) and synthesis (sorbitol, GPC), decreased degradation (GPC) and reduced osmolyte release. [HMDB] D013501 - Surface-Active Agents > D054709 - Lecithins sn-Glycero-3-phosphocholine (Choline Alfoscerate) is a precursor in the biosynthesis of brain phospholipids and increases the bioavailability of choline in nervous tissue. sn-Glycero-3-phosphocholine (Choline Alfoscerate) has significant effects on cognitive function with a good safety profile and tolerability, and is effective in the treatment of Alzheimer's disease and dementia[1][2].
4-Amino-1-[(2R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidin-2-one
3-[2-Carboxyprop-1-enyl(ethoxycarbonyl)amino]-2-methylprop-2-enoic acid
Tezacitabine
propachlor ESA
An organosulfonic acid that is 2-oxoethanesulfonic acid substituted by a phenyl(propan-2-yl)amino group at position 2. It is a metabolite of the herbicide propachlor. CONFIDENCE standard compound; EAWAG_UCHEM_ID 665 CONFIDENCE standard compound; INTERNAL_ID 2072
benserazide
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C38149 - Antiparkinsonian Agent D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 2853
3-Methylcytidine
3-Methylcytidine, a urinary nucleoside, can be used as a biomarker of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer[1].
7-hydroxy-4-(5-hydroxymethylfuran-2-yl)-2-quinolone
5-Hydroxymethyldeoxycytidin|O5-hydroxymethyl-2-deoxy-cytidine
1,6-Dihydroxy-9H-carbazole-3-carboxylic acid methyl ester
4-methoxy-3-(3-methyl-2-oxobut-3-enyl)quinolin-2(1H)-one|limonelone
3-(1H-Pyrrole-3-yl)-6-hydroxy-7-(hydroxymethyl)isocoumarin
2-[2,6-Bis(methylthio)-4-hydroxyphenyl]diazenecarboxamide
8-methoxy-6,7-dihydroxy-1-methyl-4-azafluoren-9-one|penduline
N-(beta-Glutaminylaminoethyl)-2H-Oxo-5(4H)-Isoxazolone
9-methoxy-2,2-dimethyl-6-hydro-2H-pyrano[5,6-c]quinolin-5-one
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.161 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.159
2-O-Methylcytidine
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.052 2'-O-Methylcytidine is a 2'-substituted nucleoside as a inhibitor of HCV replication. 2'-O-Methylcytidine inhibits RNA-dependent RNA polymerase (NS5B)-catalyzed RNA synthesis in vitro, in a manner that is competitive with substrate nucleoside triphosphate[1].
benthiocarb
D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
C15H15NO3_9-Methoxy-2,2-dimethyl-2,6-dihydro-5H-pyrano[3,2-c]quinolin-5-one
3-O-Methylcytidine
3′-O-Methylcytidine is a cytidine analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1].
9-Methoxy-2,2-dimethyl-2,6-dihydro-pyrano[3,2-c]quinolin-5-one
meclofenoxate
N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D020011 - Protective Agents
4-(3-Oxobutanamido)benzenesulfonic acid
C10H11NO5S (257.03579160000004)
CONFIDENCE standard compound; INTERNAL_ID 1082; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1016; ORIGINAL_PRECURSOR_SCAN_NO 1015 CONFIDENCE standard compound; INTERNAL_ID 1082; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1014; ORIGINAL_PRECURSOR_SCAN_NO 1013 CONFIDENCE standard compound; INTERNAL_ID 1082; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1026; ORIGINAL_PRECURSOR_SCAN_NO 1025 CONFIDENCE standard compound; INTERNAL_ID 1082; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1005; ORIGINAL_PRECURSOR_SCAN_NO 1004 CONFIDENCE standard compound; INTERNAL_ID 1082; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1006; ORIGINAL_PRECURSOR_SCAN_NO 1005 CONFIDENCE standard compound; INTERNAL_ID 1082; DATASET 20200303_ENTACT_RP_MIX507; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1012; ORIGINAL_PRECURSOR_SCAN_NO 1011
formetanate hydrochloride
C11H16ClN3O2 (257.09309859999996)
Mefenamic acid Metabolite (Anthranilic acid, N-(a3-hydroxy-2,3-xylyl)-)
Glycerophosphocholine
sn-Glycero-3-phosphocholine (Choline Alfoscerate) is a precursor in the biosynthesis of brain phospholipids and increases the bioavailability of choline in nervous tissue. sn-Glycero-3-phosphocholine (Choline Alfoscerate) has significant effects on cognitive function with a good safety profile and tolerability, and is effective in the treatment of Alzheimer's disease and dementia[1][2].
Acetamide, N-cyclopropyl-N-[(2,3-dichlorophenyl)Methyl]-
5-(2-chlorophenyl)-3-pyridin-2-yl-1,2,4-oxadiazole
(2R,3S)-O,O-DIACETYL-3-DIBENZYLAMINO-4-PHENYLBUTANE-1,2-DIOL
Diethyl 5-amino-3-methylthiophene-2,4-dicarboxylate
METHYL3-ISOCYANO-3-(4-TRIFLUOROMETHYLPHENYL)PROPIONATE
4-hydroxy-7-trifluoromethyl-3-quinolinecarboxylic acid
9-ETHYL-8-OXO-6,7,8,9-TETRAHYDRO-5H-CARBAZOLE-3-CARBOXYLIC ACID
2-chloro-3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
5-nitro-2-pyridin-2-yl-1,3-benzothiazole
C12H7N3O2S (257.02589620000003)
4-chloro-2-methylsulfanyl-6-pyrrolidin-1-ylpyrimidine-5-carbaldehyde
C10H12ClN3OS (257.03895719999997)
SUCCINIC ACID-MONO-N-PHENYLSULFONYLAMIDE
C10H11NO5S (257.03579160000004)
Benzenesulfonamide,4-amino-N-(4,5-dihydro-2-thiazolyl)-
1-(4-Bromo-2-fluorobenzyl)pyrrolidine
C11H13BrFN (257.02153300000003)
Timoprazole
C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29723 - Proton Pump Inhibitor D004791 - Enzyme Inhibitors > D054328 - Proton Pump Inhibitors
3-amino-6-methyl-4-(trifluoromethyl)thieno[2,3-b]pyridine-2-carbonitrile
2-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine hcl
5(1-HYDROXYETHYL)-3(4-TRIFLUOROMETHYLPHENYL)-ISOXAZOLE
6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-1-carboxylic acid ethyl ester hydrochloride
4-Methyl-2-(2-nitrophenyl)azophenol
C13H11N3O3 (257.08003759999997)
3-(4-methoxy-3-nitrophenyl)propanethioic S-acid
C10H11NO5S (257.03579160000004)
3-chloro-2-fluoropyridine-4-boronic acid, pinacol ester
5-Chloro-2-fluoropyridine-4-boronic acid pinacol ester
4-Benzyl-2-morpholinecarboxylic Acid Hydrochloride
alpha-(N,N-Dimethylamino)ethylferrocene
C14H19FeN (257.08668040000003)
1-(3-nitrophenyl)-2H-pyrazolo[3,4-d]pyrimidin-4-one
C11H7N5O3 (257.05488720000005)
1H-PYRROLE-2,5-DIONE, 1-[4-(TRIFLUOROMETHOXY)PHENYL]-
ETHYL 8-AMINO-7-CHLORO-2,3-DIHYDROBENZO[B][1,4]DIOXINE-5-CARBOXYLATE
Methyl (2S,4S)-4-phenoxy-2-pyrrolidinecarboxylate(HCl)
5-(3-Trifluoromethylphenyl)-oxazole-4-carboxylic acid
(S)-3-(3-ACETYL-4-HYDROXY-PHENYL)-2-AMINO-PROPIONICACIDMETHYLESTER
1-phenyl-7-(trifluoromethyl)azepan-2-one
C13H14F3NO (257.10274300000003)
(R)-4-(6-METHOXYNAPHTHALEN-2-YL)-4-METHYLOXAZOLIDIN-2-ONE
(PIPERIDIN-4-YL)(4-TRIFLUOROMETHYLPHENYL)METHANONE
C13H14F3NO (257.10274300000003)
trimethyl-[(3-trimethylsilyloxy-1,2,4-triazin-5-yl)oxy]silane
1-BENZYL-2,5-BIS(CHLOROMETHYL)PYRROLIDINE
C13H17Cl2N (257.07379820000006)
ethene,(Z)-4-ethoxy-4-oxobut-2-enoic acid,2-methylprop-2-enoate
1-(6-Methylpyridin-3-yl)-2-(4-(Methylthio)phenyl)ethanone
2-Chloro-3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Isoquinoline,3,4-dihydro-1-(phenylmethyl)-, hydrochloride (1:1)
Benzamide,N-(4-aminophenyl)-4-nitro-
C13H11N3O3 (257.08003759999997)
Ethyl 5-aminobenzo[b]thiophene-2-carboxylate hydrochloride
7-Methyl-3a-(trifluoromethyl)-3,3a-dihydrobenzo[d]pyrrolo[2,1-b]oxazol-1(2H)-one
5-Fluoro-3H-spiro[isobenzofuran-1,4-piperidin]-3-one
C12H13ClFNO2 (257.06188000000003)
3-chloro-2-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
N-(3-Cyano-6-methoxy-4-oxo-1,4-dihydro-7-quinolinyl)acetamide
C13H11N3O3 (257.08003759999997)
N-(3-Cyano-4-hydroxy-7-methoxy-6-quinolinyl)acetamide
C13H11N3O3 (257.08003759999997)
2-C-Methylcytidine
NM107 (2'-C-Methylcytidine) is an nucleoside inhibitor of the hepatitis C virus (HCV) NS5B polymerase, the EC50 of NM107 in the wild-type replicon cells is 1.85 μM[1][2].
Carbamic acid, (4-methoxyphenyl)-, phenylmethyl ester (9CI)
(6-Chloroimidazo[1,2-b]pyridazin-3-yl)(phenyl)methanone
4-nitro-N-(pyridin-4-ylmethyl)benzamide
C13H11N3O3 (257.08003759999997)
(6-chloropyridin-3-yl)-(1H-pyrrolo[2,3-b]pyridin-3-yl)methanone
diethyl(aminomethyl)phosphonate oxalate salt
C7H16NO7P (257.06643560000003)
2-[(5-METHYL-FURAN-2-CARBONYL)-AMINO]-4-METHYLSULFANYL-BUTYRIC ACID
Benzoylpas
D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent
5,5-DIMETHYL-2-PHENYL-5,6-DIHYDROBENZO[D]THIAZOL-7(4H)-ONE
METHYL 5-CYANO-2-OXO-5-PHENYLCYCLOHEXANECARBOXYLATE
(2-AMINO-2-PHENYL-ETHYL)-CARBAMICACIDTERT-BUTYLESTER
6-pyrazin-2-ylthieno[3,2-b]pyridine-3-carboxylic acid
C12H7N3O2S (257.02589620000003)
3-(o-Chlorophenyl)-3-hydroxy-3-phenylpropiononitrile
METHYL 6-METHOXY-1,2,3,4-TETRAHYDROQUINOLINE-2-CARBOXYLATE HCL
8-ACETYL-3A,4,5,9B-TETRAHYDRO-3 H-CYCLOPENTA[ C ]QUINOLINE-4-CARBOXYLIC ACID
4-HYDROXY-2-(TRIFLUOROMETHYL)QUINOLINE-3-CARBOXYLIC ACID
Ethyl 2-(5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)acetate hydrochloride
C11H16ClN3O2 (257.09309859999996)
Ethyl 2-(5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)acetate hydrochloride
C11H16ClN3O2 (257.09309859999996)
3-amino-2-methyl-5-phenylthieno[2,3-d]pyrimidin-4-one
2-benzyl-4,6,7,7a-tetrahydro-3aH-isoindole-1,3,5-trione
Acetamide,2-chloro-N-[2-(3,4-dimethoxyphenyl)ethyl]-
2-(3,4-DICHLOROPHENYL)PENT-4-ENOIC ACID N-METHYLAMIDE
Pyridine,4-[5-(2-chlorophenyl)-1,2,4-oxadiazol-3-yl]-
2-[(Dimethylamino)methylene]-3-oxo-3-(2,4-dichlorophenyl)propane
2-Chloro-6-fluoropyridine-4-boronic acid,pinacol ester
(s)-(-)-n,n-dimethyl-1-ferrocenylethylamine
C14H19FeN (257.08668040000003)
[(1R)-1-(Dimethylamino)ethyl]ferrocene
C14H19FeN (257.08668040000003)
[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-5-yl]methanol
(S)-TERT-BUTYL1-([1,2,4]TRIAZOLO[4,3-A]PYRIDIN-3-YL)ETHYLCARBAMATE
2-[2-([1,3,4]THIADIAZOL-2-YLCARBAMOYL)-ETHYL]-PENTANOIC ACID
5-Chloro-2-fluoropyridine-3-boronic acid pinacol ester
1H-Imidazole-2-carboxamide,4,5-dihydro-N-[4-(trifluoromethyl)phenyl]-(9CI)
2-(3-FLUORO-4-HYDROXY-PHENYL)-PYRANO[2,3-B]PYRIDIN-4-ONE
Thiazolidine, 2-(4-methylphenyl)-3-(methylsulfonyl)- (9CI)
Benzoic acid,5-[2-(4-aminophenyl)diazenyl]-2-hydroxy-
C13H11N3O3 (257.08003759999997)
6-amino-4-hydroxy-2-naphthalenesulfonic&
C10H11NO5S (257.03579160000004)
Benzoic acid, 2-(3-formyl-2,5-dimethyl-1H-pyrrol-1-yl)-, methyl ester (9CI)
4-oxo-6-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxylic acid
(E)-3-(2,2-DIMETHYL-[1,3]DIOXOLAN-4-YL)-ACRYLICACIDETHYLESTER
1-hexyl-4-methylpyridin-1-ium,bromide
C12H20BrN (257.07790200000005)
6-(4-fluorophenyl)-1H-pyrido[3,2-d]pyrimidine-2,4-dione
3-Pyrrolidinecarboxylic acid, 4-(3-methoxyphenyl)-, hydrochloride (1:1), (3S,4R)-
2-O-methyl 4-O-propyl 5-amino-3-methylthiophene-2,4-dicarboxylate
4-Hydroxy-6-(trifluoromethyl)-3-quinolinecarboxylic acid
5-[N-(tert-butoxycarbonyl)-N-methylamino]-2-thiophenecarboxylic acid
Hydrazinecarbothioamide,N-(4-cyclopropyl-1-naphthalenyl)-
3-[(4-CHLORO-3-ETHYL-1-METHYL-1H-PYRAZOL-5-YL)CARBONYL]-2-OXAZOLIDINONE
4-Hydroxy-1-(2-C-Methyl--D-ribofuranosyl)- 2(1H)-pyridinone
2-Chloro-N-(3-chloro-benzyl)-N-cyclopropyl-acetaMide
4-Benzyl-morpholine-3-carboxylic acid hydrochloride
2-(2-hydroxyacetyl)-1,8-dimethylimidazo[1,2-a]quinoxalin-4(5H)-one
C13H11N3O3 (257.08003759999997)
2-Chloro-5-fluoropyridine-4-boronic acid pinacol ester
1-Bromo-3-fluoro-5-piperidinobenzene
C11H13BrFN (257.02153300000003)
2,4-THIAZOLEDICARBOXYLICACID,4-(1,1-DIMETHYLETHYL)2-ETHYLESTER
{[4-AMINO-5-(ETHOXYCARBONYL)PYRIMIDIN-2-YL]THIO}ACETIC ACID
1-hexyl-3-methylpyridin-1-ium,bromide
C12H20BrN (257.07790200000005)
4-chloro-2-(4,5-dihydro-1H-imidazol-2-yl)-1,3-dihydroisoindole
(4-(N-Isopropylsulfamoyl)-2-methylphenyl)boronic acid
(2-Methyl-4-(N-propylsulfamoyl)phenyl)boronic acid
o-(2-methoxyethoxy)-benzene sulfonyl isocyanate
C10H11NO5S (257.03579160000004)
4-chloro-6-(4-methylpiperazin-1-yl)-5-nitropyrimidine
4-Hydroxy-8-(trifluoromethyl)quinoline-3-carboxylic acid
Tetraethylammonium Iodide
D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators
2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carboxylic acid
3-TERT-BUTOXYCARBONYLAMINO-THIOPHENE-2-CARBOXYLIC ACID METHYL ESTER
Tezacitabine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor D011838 - Radiation-Sensitizing Agents D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
4-Amino-5-methyl-1-pentofuranosyl-2(1h)-pyrimidinone
Fluorocyclopentenylcytosine
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor
Ethyl 4-oxo-1,4-dihydropyrimido[1,2-a]benzimidazole-3-carboxylate
C13H11N3O3 (257.08003759999997)
cephalosporanic acid
C10H11NO5S (257.03579160000004)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams
4-Amino-1-[4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]pyrimidin-2-one
N4-Methylcytidine
N4-Methylcytidine (Nsc518744) is a cytidine nucleoside analog. Cytidine analogs have a mechanism of inhibiting DNA methyltransferases (such as Zebularine, HY-13420), and have potential anti-metabolic and anti-tumor activities[1].
(E)-1-(benzofuran-2-yl)-3-morpholinoprop-2-en-1-one
N-(4,6-difluoro-1,3-benzothiazol-2-yl)propanehydrazide
2,4-Dimethyl-1H-[1,3,5]triazino[1,2-a]quinoline-1,3,6(2H,4H)-trione
C13H11N3O3 (257.08003759999997)
2-[Hydroxy(4-nitrophenyl)methyl]cyclohepta-2,4,6-trien-1-one
2-Hydroxy-3-(4-nitrobenzyl)-2,4,6-cycloheptatrien-1-one
2-Fluoro-4-[4-(4-Fluorophenyl)-1h-Pyrazol-3-Yl]pyridine
Choline alfoscerate
A member of the class of phosphocholines that is the choline ester of sn-glycero-3-phosphate. It is one of the major osmolyte in the renal medullary cells. N - Nervous system > N07 - Other nervous system drugs > N07A - Parasympathomimetics C78272 - Agent Affecting Nervous System > C47796 - Cholinergic Agonist D013501 - Surface-Active Agents > D054709 - Lecithins COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS sn-Glycero-3-phosphocholine (Choline Alfoscerate) is a precursor in the biosynthesis of brain phospholipids and increases the bioavailability of choline in nervous tissue. sn-Glycero-3-phosphocholine (Choline Alfoscerate) has significant effects on cognitive function with a good safety profile and tolerability, and is effective in the treatment of Alzheimer's disease and dementia[1][2].
alpha-(2,6-anhydro-3-deoxy-D-arabino-heptulopyranosid)onate 7-phosphonate
[3-(2-hydroxyethyl)-1H-indol-5-yl] hydrogen sulfate
C10H11NO5S (257.03579160000004)
5-amino-5-oxo-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]pentanoic acid
9-Hydroxy-7,7-dimethyl-6,8-dihydrocyclopenta[g]isoquinoline-5-carboxylic acid
4-amino-1-[(3E)-3-(fluoromethylidene)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
3-[2-Carboxyprop-1-enyl(ethoxycarbonyl)amino]-2-methylprop-2-enoic acid
N-(4-phenylmethoxyphenyl)carbamic acid methyl ester
pyrazolo[5,1-c][1,2,4]benzotriazin-8-yl N,N-dimethylcarbamate
(E)-N-(1,3-benzodioxol-5-yl)-3-(furan-2-yl)prop-2-enamide
2-acetamidoethyl [(2R)-2,3-dihydroxypropyl] hydrogen phosphate
C7H16NO7P (257.06643560000003)
3-(2-furanyl)-4-(2-methylphenyl)-1H-1,2,4-triazole-5-thione
2-Quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester
Norrubrofusarin(1-)
A phenolate anion obtained by deprotonation of the 5-hydroxy group of norrubrofusarin. It is the major microspecies at pH 7.3.
[(2R,3S,4R,5R)-5-amino-3,4-dihydroxy-6-oxooxan-2-yl]methyl dihydrogen phosphate
(2S)-2,3-dihydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate
[3-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] acetate
C7H16NO7P (257.06643560000003)
2-Aminoethyl (2-hydroxy-3-propoxypropyl) hydrogen phosphate
cobalt(2+);(Z)-4-oxopent-2-en-2-olate;(E)-4-oxopent-2-en-2-olate
C10H14CoO4 (257.02240240000003)
4-Acetonyl-3-methyl-1-para-tolyl-3-pyrroline-2,5-dione
tolmetin
M - Musculo-skeletal system > M02 - Topical products for joint and muscular pain > M02A - Topical products for joint and muscular pain > M02AA - Antiinflammatory preparations, non-steroids for topical use M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AB - Acetic acid derivatives and related substances D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors
Pyroglutamylglutamine
A dpeptide obtained by formal condensation of the carboxy group of L-pyroglutamine with the amino group of L-glutamine
Glycerylphosphorylcholine
D013501 - Surface-Active Agents > D054709 - Lecithins
9-methoxy-2,2-dimethyl-6H-pyrano[3,2-c]quinolin-5-one
(3-chloro-2,4,6-trihydroxyphenyl)hexan-1-one(1-)
A phenolate anion resulting from the removal of a proton from the phenolic hydroxy group of (3-chloro-2,4,6-trihydroxyphenyl)hexan-1-one that is para to the hexanoyl group. It is the major species at pH 7.3.
(RS)-APICA
(RS)-APICA is a selective group II metabotropic glutamate receptor (mGluR II) antagonist. (RS)-APICA shows potential neuroprotective effect[1].
7,8-dihydroxy-6-methoxy-4-methylindeno[1,2-b]pyridin-5-one
(3s,4s,5r)-3-chloro-5-(hydroxymethyl)-4-(4-hydroxyphenoxy)-4,5-dihydro-3h-pyrrol-2-ol
(2s)-2-amino-4-{[2-(5-oxo-1,2-oxazol-2-yl)ethyl]-c-hydroxycarbonimidoyl}butanoic acid
2,3-dihydroxy-4-methyl-3h,4h-benzo[g]quinoline-5,10-dione
3-oxa-8-azatricyclo[3.2.1.0²,⁴]octan-6-yl 2-phenylprop-2-enoate
(2s,3ar,4r,7ar)-4-hydroxy-6-(methoxycarbonyl)-2-methyl-3a,4,5,7a-tetrahydro-1,3-benzodioxole-2-carboximidic acid
6,9-dihydroxy-8-methoxy-4-methylindeno[1,2-b]pyridin-5-one
1,3,5-trihydroxyacridone; n-me
{"Ingredient_id": "HBIN001069","Ingredient_name": "1,3,5-trihydroxyacridone; n-me","Alias": "NA","Ingredient_formula": "C14H11NO4","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9557","PubChem_id": "NA","DrugBank_id": "NA"}
2-benzamidobenzoic acid; 2'-hydroxy
{"Ingredient_id": "HBIN005345","Ingredient_name": "2-benzamidobenzoic acid; 2'-hydroxy","Alias": "NA","Ingredient_formula": "C14H11NO4","Ingredient_Smile": "NA","Ingredient_weight": "257.24","OB_score": "NA","CAS_id": "13316-98-8","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8692","PubChem_id": "NA","DrugBank_id": "NA"}
1,7-dihydroxy-6-methoxy-9h-carbazole-3-carbaldehyde
4-hydroxy-2-{[hydroxy(phenyl)methylidene]amino}benzoic acid
7,9-dihydroxy-8-methoxy-4-methylindeno[1,2-b]pyridin-5-one
(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl 1h-pyrrole-2-carboxylate
8-hydroxy-2-methyl-5h-chromeno[4,3-b]pyridine-10-carboxylic acid
n-(2-{[(2r)-2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy}ethyl)ethanimidic acid
C7H16NO7P (257.06643560000003)
(3r,4r)-2,3-dihydroxy-4-methyl-3h,4h-benzo[g]quinoline-5,10-dione
4,6-dihydroxy-2-(4-hydroxyphenyl)-3h-isoindol-1-one
7-hydroxy-3-methoxy-6-methyl-9h-carbazole-1,4-dione
3-chloro-5-(hydroxymethyl)-4-(4-hydroxyphenoxy)-4,5-dihydro-3h-pyrrol-2-ol
n-(2-{[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy}ethyl)ethanimidic acid
C7H16NO7P (257.06643560000003)